Advertisement
Screener

OCUGEN, INC. (OCGN) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

OCUGEN, INC. Cash Flow Breakdown

Cash flow breakdown shows where OCUGEN, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $56.96M went out.
  • Fiscal year ended 2025-12-31: from investing, $311.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $17.33M came in.
  • Fiscal year ended 2025-12-31: change in cash, $39.93M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$56.96M-$311.00K$0.00$19.85M-$2.53M*-$39.93M
2024-12-31-$42.14M-$3.38M$30.00M$38.56M-$3.70M*$19.36M
2023-12-31-$62.05M$3.08M$500.00K$20.80M-$38.10M
2022-12-31-$60.08M-$16.97M$500.00K*$59.57M-$17.55M
2021-12-31-$47.94M-$1.82M$0.00$0.00$0.00$129.21M-$8.54M*$70.92M
2020-12-31-$14.71M-$307.00K$0.00-$5.63M$37.82M-$586.00K*$16.59M
2019-12-31-$16.89M-$2.36M-$48.00K-$5.29M$1.18M$29.22M*$5.82M
2018-12-31-$11.63M-$77.41K$0.00$0.00$0.00$7.18M*-$4.52M
2017-12-31-$23.02M-$1.23M-$583.00K$6.00K-$24.83M
2016-12-31-$25.74M-$320.00K-$583.00K$2.00K$27.63M*$993.00K
2015-12-31-$30.03M-$1.95M-$406.00K$4.74M-$27.61M
2014-12-31-$17.94M-$3.32M$1.75M$26.00K$69.28M*$49.79M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$12.20M*-$21.00K*$80.37M*
2026-03-31-$21.79M-$6.00K$22.50M$12.48M*$13.29M
2025-12-31-$13.96M*-$35.00K*
2025-09-30-$12.92M*-$86.00K*$18.51M*
2025-06-30-$10.73M*-$88.00K*
2025-03-31-$19.36M-$102.00K$0.00-$1.25M*-$20.71M
2024-12-31-$10.36M*-$13.00K*$30.00M*$981.00K*
2024-09-30-$11.27M*-$507.00K*$0.00*$34.79M*
2024-06-30-$9.91M*-$513.00K*
2024-03-31-$10.60M-$2.35M-$145.00K-$13.09M
2023-12-31-$11.30M*-$2.72M*$0.00*$16.00K*
2023-09-30-$13.71M*-$3.37M*$0.00*$98.00K*
2023-06-30-$18.81M*$5.72M*$14.96M*
2023-03-31-$18.24M$3.44M$5.73M-$9.30M
2022-12-31-$16.91M*-$15.29M*$0.00*$8.43M*
2022-09-30-$14.30M*-$83.00K*$500.00K*-$9.00K*$603.00K*
2022-06-30-$13.80M*-$1.37M*$361.00K*
2022-03-31-$15.07M-$223.00K$50.18M$34.81M
2021-12-31-$12.80M*-$192.00K*$0.00*$0.00*$605.00K*
2021-09-30-$8.05M*-$350.00K*$0.00*$0.00*$0.00*$110.00K*
2021-06-30-$21.80M*-$1.01M*$100.37M*-$6.71M*
2021-03-31-$5.28M-$261.00K$28.13M-$1.83M*$20.75M
2020-12-31-$4.28M*-$251.00K*-$1.26M*$11.13M*
2020-09-30-$2.65M*-$22.00K*-$3.22M*$0.00*$10.53M*
2020-06-30-$3.09M*$19.00K*$16.16M*-$1.32M*
2020-03-31-$4.69M-$53.00K$0.00-$4.25M
2019-12-31-$8.74M*-$20.87K*$183.17K*$723.96K*
2019-09-30-$2.12M*-$2.20M*-$168.00*$18.95M*
2019-06-30-$3.36M*-$121.49K*$3.85M*
2019-03-31-$2.67M-$10.58K$1.36M*-$1.32M
2018-12-31-$2.79M*$0.00*$178.00K*-$8.16M*$9.92M*
2018-09-30-$3.08M*-$793.00*$0.00*$2.43M*-$3.14M*
2018-06-30-$9.05M*$278.38K*-$45.00K*$0.00*
2018-03-31$3.29M-$355.00K-$133.00K$5.73M$8.43M
2017-12-31-$4.32M*$747.00K*-$146.00K*$1.00K*-$3.72M*
2017-09-30-$5.73M*$6.10M*-$146.00K*$236.00K*
2017-06-30-$5.63M*-$38.00K*-$145.00K*-$5.81M*
2017-03-31-$7.34M-$8.04M-$146.00K-$15.53M
2016-12-31-$5.89M*-$3.00K*-$146.00K*$0.00*-$6.09M*
2016-09-30-$5.46M*-$3.00K*-$146.00K*$27.68M*$22.07M*
2016-06-30-$6.54M*-$282.00K*-$145.00K*-$6.97M*
2016-03-31-$7.84M-$32.00K-$146.00K$1.00K-$8.02M
2015-12-31-$7.00M*-$131.00K*-$146.00K*$0.00*-$7.28M*
2015-09-30-$6.88M*-$498.00K*-$146.00K*$0.00*-$7.50M*
2015-06-30-$7.47M*-$405.00K*-$101.00K*$0.00*-$7.96M*
2015-03-31-$8.69M-$915.00K-$13.00K$4.74M-$4.88M
2014-12-31-$4.68M*-$1.74M*$1.29M*$0.00*$60.41M*$55.27M*
2014-09-30-$2.79M*-$1.38M*$1.00K*-$4.52M*
2014-06-30-$5.45M*-$73.00K*$9.94M*$4.42M*
2014-03-31-$5.02M-$120.00K-$5.37M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
AGENUS INC (AGEN)United States$0.383B1.41
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
Surrozen, Inc./DE (SRZN)United States$0.395B